Results 81 to 90 of about 27,813 (176)

Clinical Outcomes After Catheter Ablation in Patients With Structural Heart Disease and Ventricular Fibrillation

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Introduction In patients with ischemic cardiomyopathy (ICM), recurrent VF may be treated with catheter ablation by targeting triggering premature ventricular complexes (PVCs) and/or ventricular scar homogenization. Data on optimal ablation strategies in patients with non‐ischemic cardiomyopathy (NICM) remain limited.
Kenji Hashimoto, Samual Turnbull, Saurabh Kumar   +2 more
wiley   +1 more source

An implantable cardioverter defibrillator in a patient with triple mechanical valves

Clinical Case Reports, 2018
Key Clinical Message A patient with permanent atrial fibrillation, triple mechanical prosthetic valve replacements, and nonischemic cardiomyopathy presented with symptomatic high‐grade atrioventricular block.
Alex W. X. Tan, Kah L. Ho, Chi K. Ching, Kelvin C. M. Chua   +3 more
doaj   +1 more source

First United States Experience With Focal Pulsed‐Field Ablation Using the FARAPOINT Catheter for Refractory Ventricular Tachycardia

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Drug‐refractory ventricular tachycardia (VT) after failed radiofrequency (RF) ablation remains a clinical challenge. Pulsed‐field ablation (PFA) is expanding to ventricular applications, but United States experience with focal pulsed‐field‐only catheters in VT is sparse, and pulsed‐field platforms are not equivalent across ...
Jorge L. Reyes, Rezwan Munshi, Collin Goebel, Venkat Tholakanahalli   +3 more
wiley   +1 more source

Feasibility, Safety, and Efficacy of Pulsed Field Ablation for Ventricular Arrhythmias: Insights From a Large Health System Registry in the United States

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Pulsed field ablation (PFA) is an emerging non‐thermal ablation modality with proven safety in atrial arrhythmia ablation. However, data on its performance for ventricular arrhythmias (VA) remain limited. Objective To evaluate the feasibility, safety, and efficacy of PFA for complex VA in a multicenter real‐world US registry ...
Narut Prasitlumkum, Juan F. Rodriguez‐Riascos, Hema Vemulapalli, Aakash Somappa, Camilo A. Estrada‐Vargas, Olubadewa A. Fatunde, Carlos A. Rojas, Poojan Prajapati, Keerthika Vijayakumar, Suraj Kapa, Duy Nguyen, Samuel Asirvatham, Malini Madhavan, Christopher McLeod, Hicham Z. El Masry, Abhishek J. Deshmukh, Danesh K. Kella, Ammar M. Killu, Siva K. Mulpuru, Mayank Sardana, Luis R. Scott, Alan M. Sugrue, Komandoor Srivathsan   +22 more
wiley   +1 more source

Validation of Cardiorespiratory‐Gated Proton Beam Delivery for Stereotactic Arrhythmia Radioablation

Journal of Cardiovascular Electrophysiology, EarlyView.
Stereotactic arrhythmia radioablation (STAR) with scanned proton beams was performed in a porcine model targeting the left ventricular free wall (A). Dual gating synchronized proton delivery with both respiratory and cardiac motion was compared to single gating using only respiratory motion (B).
Jagdip Kang, Felicitas J. Bijari, Yanis Chemli, Yen‐Lin Chen, Helen Deng, Nicolas Depauw, Maeva Dhaynaut, Adriano Garonna, Hyeongseok Kim, Marina Macdonald‐Soccorso, Sung‐Hyun Moon, Marc D. Normandin, Rebecca Woodcock, K. Moshe Yaghoubian, Georges El Fakhri, Robert Levine, Kyung‐Wook Jee, H. Immo Lehmann   +17 more
wiley   +1 more source

QT Interval Evaluation in Right Ventricular Pacing: Validation of a Novel Formula

Pacing and Clinical Electrophysiology, EarlyView.
Abstract Background QT interval measurement in the presence of right ventricular pacing (RVP) represents a clinical challenge. We therefore aimed to derive and validate a formula for QT estimation during RVP in a large cohort of pacemaker patients. Methods and Results We prospectively enrolled 100 patients in a derivation cohort and 487 in a validation
Amr Abdin, Alhasan Almasri, Ibrahim Antoun, Charles Gieres, Christian Werner, Yvonne Bewarder, Christian Ukena, Igor Schwantke, Michael Böhm, Saarraaken Kulenthiran   +9 more
wiley   +1 more source

Safety and Performance of INVICTA DF4 Ventricular Defibrillation Lead: Results From APOLLO Prospective Multicenter Study

Pacing and Clinical Electrophysiology, EarlyView.
Abstract Background Implantable cardioverter‐defibrillator (ICD) therapy relies on reliable right ventricular leads for pacing, sensing, and defibrillation. The INVICTA DF4 lead is an active‐fixation, quadripolar design intended to optimize implant workflow and long‐term safety and performance. Methods APOLLO was a prospective, multicenter, single‐arm,
Klaus K. Witte, Juan Gabriel Martínez, Mário M. Oliveira, Alberto Barrera, Maite Izquierdo, Cosimo Mandurino, Maria Emilce Trucco, José Juan García Salvador, Antoine Dompnier, Frédéric Jean, Pablo J. Sánchez Millán, Carsten Israel, Maria Martino, Pedro Marques   +13 more
wiley   +1 more source

First Experience With Extravascular Implantable Cardioverter‐Defibrillator Under Deep Sedation

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The Extravascular Implantable Cardioverter‐Defibrillator (EV‐ICD) utilizes a substernal lead to provide defibrillation and anti‐tachycardia pacing (ATP) while avoiding transvenous complications. General anesthesia (GA) was applied for implantation procedures in the EV‐ICD pivotal trial and is currently recommended by the ...
Nibras Soubh, Bernhard C. Danner, Ulrich Krause, Matthias J. Müller, Markus Zabel, Gerd Hasenfuß, Constanze Schmidt, Helge Haarmann, Eva Rasenack, Leonard Bergau   +9 more
wiley   +1 more source

Impact of ICD Presence in Patients With Left Ventricular Assist Devices for End‐Stage Heart Failure

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The prognostic relevance of implantable cardioverter defibrillator (ICD) in patients with end‐stage heart failure (HF) with left ventricular assist device (LVAD) remains controversial. Objectives To evaluate the prognostic impact of ongoing use of ICD and associated complications in HF‐patients with LVAD‐implantation.
Nafilah Baridwan, Mustafa Gerçek, Muhammed Gerçek, Michiel Morshuis, Thomas Eitz, René Schramm, Volker Rudolph, Jan F. Gummert, Philipp Sommer, Christian Sohns, Angelika Costard‐Jäckle, Guram Imnadze   +11 more
wiley   +1 more source

Transvenous Lead Extraction Versus Abandonment of non‐Infected, Superfluous Leads—A Meta‐Analysis and Systematic Review

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background Managing non‐functional cardiac implantable electronic device (CIED) leads remains controversial. While extraction is standard for infection, it is unclear whether transvenous lead extraction (TLE) or lead abandonment (LA) provides superior outcomes for superfluous leads.
Karanjeet Chauhan, Philip Jakanovski, Thalys Sampaio Rodrigues, Marwan Shawki, Nicholas Sclavos, Louise Segan, Neil Strathmore, Alistair Royse, Gareth Wynn   +8 more
wiley   +1 more source